Novel functionalized 5- (phenoxymethyl) -1,3-dioxane analogs exhibiting cytochrome P450 inhibition

摘要

The pharmaceutical composition described in this document includes metabolic syndrome, obesity, headache, depression, hypertension, diabetes mellitus, Cushing syndrome, pseudo-Cushing syndrome, cognitive dysfunction, dementia, heart failure, renal failure, psoriasis, 5- (phenoxymethyl) has a disease-modifying action in the treatment of diseases associated with the production of cortisol, including glaucoma, cardiovascular disease, cancer, stroke, incidental tumors, or any disease involving excessive production of cortisol Includes -1,3-dioxane analogs.